Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer
- 1 October 2004
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 95 (1) , 264-266
- https://doi.org/10.1016/j.ygyno.2004.06.039
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Risk of Malignant Mixed Mullerian Tumors After Tamoxifen Therapy for Breast CancerJNCI Journal of the National Cancer Institute, 2004
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecologic Cancer, 2002
- Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: Report of five cases and review of the literatureInternational Journal of Gynecologic Cancer, 2002
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Tamoxifen and the EndometriumInternational Journal of Gynecological Pathology, 1999
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Parity as an Independent Prognostic Factor in Malignant Mixed Mesodermal Tumors of the EndometriumGynecologic Oncology, 1997
- Postmenopausal Tamoxifen Treatment and Endometrial PathologyObstetrical & Gynecological Survey, 1994